Treatment Effects of Short-Term Continuous Positive Airway Pressure on Blood Glucose Control in Type 2 Diabetic Patients with Obstructive Sleep Apnea Syndrome

References

• Tiihonen M, Partinen M, Narvanen S. The severity of obstructive sleep apnoea is associated with insulin resistance. J Sleep Res. 1993;2(1):56–61. doi:10.1111/j.1365-2869.1993.tb00062.x10607072
   PubMed Web of Science ®Google Scholar
• Vgontzas AN, Papanicolaou A, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000;85(3):1151–1158. doi:10.1210/jcem.85.3.648410720054
   PubMed Web of Science ®Google Scholar
• Punjabi MN, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002;165(5):677–682. doi:10.1164/ajrccm.165.5.210408711874813
   PubMed Web of Science ®Google Scholar
• Coughlin SR, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25(9):735–741. doi:10.1016/j.ehj.2004.02.02115120883
   PubMed Web of Science ®Google Scholar
• Saini J, Krieger J, Brandenberger G, et al. Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res. 1993;25(07):375–381. doi:10.1055/s-2007-10021238406324
   PubMed Web of Science ®Google Scholar
• Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab. 1994;79:1681–1685.7989475
   PubMed Web of Science ®Google Scholar
• Cooper BG, White JE, Ashworth LA, et al. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep. 1995;18:172–179.7610313
   PubMed Web of Science ®Google Scholar
• Smurra M, Philip P, Taillard J, et al. CPAP treatment does not affect glucose–insulin metabolism in sleep apneic patients. Sleep Med. 2001;2(3):207–213. doi:10.1016/S1389-9457(00)00079-411311683
   PubMed Web of Science ®Google Scholar
• Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004;169(2):156–162. doi:10.1164/rccm.200302-206OC14512265
   PubMed Web of Science ®Google Scholar
• Czupryniak L, Loba J, Pawlowski M, et al. Treatment with continuous positive airway pressure may affect blood glucose levels in nondiabetic patients with obstructive sleep apnea syndrome. Sleep. 2005;28(5):601–603. doi:10.1093/sleep/28.5.60116171273
   PubMed Web of Science ®Google Scholar
• Mastrototaro J. The MiniMed continuous glucose monitoring system (CGMS). J Pediatr Endocrinol Metab. 1999;12(Suppl3):751–758.10626266
   PubMed Web of Science ®Google Scholar
• Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27(6):1487–1495. doi:10.2337/diacare.27.6.1487
   Google Scholar
• Pallayova M, Donic V, Tomori Z. Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus. Diabetes Res Clin Pract 2008;81(1):e8–e11. doi:10.1016/j.diabres.2008.03.012
   Google Scholar
• Dawson A, Abel SL, Loving RT, et al. CPAP Therapy of Obstructive Sleep Apnea in Type 2 Diabetics Improves Glycemic Control during Sleep. J Clin Sleep Med 2008;4(06):538–542. doi:10.5664/jcsm.27347
   Google Scholar
• Shaw JE, Punjabi NM, Naughton MT, et al. The Effect of Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes. Am J Respir Crit Care Med 2016;194(4):487–492. doi:10.1164/rccm.201511-2260OC
   Google Scholar
• Pamidi S, Wroblewski K, Stepien M, et al. Eight Hours of Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Improves Glucose Metabolism in Patients with Prediabetes. A Randomized Controlled Trial. Am J Respir Crit Care Med 2015;192(1):96–105. doi:10.1164/rccm.201408-1564OC
   Google Scholar
• Drager LF, Brunoni AR, Jenner R, Lorenzi-Filho G, Benseñor IM, Lotufo PA. Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomised trials. Thorax 2015;70(3):258–264. doi:10.1136/thoraxjnl-2014-205361
   Google Scholar
• Harsch IA, Schahin SP, Bruckner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration. 2004;71(3):252–259. doi:10.1159/00007742315133345
   PubMed Web of Science ®Google Scholar
• Weinstock TG, Wang X, Rueschman M, et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep. 2012;35(5):617–625. doi:10.5665/sleep.181622547887
   PubMed Web of Science ®Google Scholar
• Muggeo M, Zoppini G, Bonora E, et al. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care 2000;23(1):45–50. doi:10.2337/diacare.23.1.45
   Google Scholar
• Gimeno-Orna JA, Castro-Alonso FJ, Boned-Juliani B, et al. Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients. J Diabetes Complications 2003;17(2):78–81. doi:10.1016/S1056-8727(02)00197-6
   Google Scholar
• Babu AR, Herdegen J, Fogelfeld L, et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005;165(4):447–452. doi:10.1001/archinte.165.4.447
   Google Scholar